Literature DB >> 20008204

Thrombocytopenia and thrombosis in disseminated intravascular coagulation (DIC).

Craig S Kitchens1.   

Abstract

Disseminated intravascular coagulation (DIC) is the physiologic result of pathologic overstimulation of the coagulation system. Despite multiple triggers, a myriad of laboratory abnormalities, and a clinical presentation ranging from gross hemostatic failure to life-threatening thrombosis, or even both simultaneously, a simplified clinical approach augmented by a few readily available tests allows prompt identification of the process and elucidation of treatment opportunities. Platelet counts in DIC may be low, especially in acute sepsis-associated DIC, yet increased in malignancy-associated chronic DIC. Thrombotic risk is not a function of the platelet count, and thrombocytopenia does not protect the patient from thrombosis. The stratification of both thrombotic risk and hemorrhagic risk will be addressed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20008204     DOI: 10.1182/asheducation-2009.1.240

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


  20 in total

1.  [Successful use of C1 esterase inhibitor in capillary leak syndrome].

Authors:  R Seidel
Journal:  Anaesthesist       Date:  2012-11       Impact factor: 1.041

2.  SARS-CoV-2 induced thrombocytopenia as an important biomarker significantly correlated with abnormal coagulation function, increased intravascular blood clot risk and mortality in COVID-19 patients.

Authors:  Changqian Bao; Xiandong Tao; Wei Cui; Bin Yi; Tiewen Pan; Ken H Young; Wenbin Qian
Journal:  Exp Hematol Oncol       Date:  2020-07-17

Review 3.  Haematological interventions for treating disseminated intravascular coagulation during pregnancy and postpartum.

Authors:  Arturo J Martí-Carvajal; Gabriella Comunián-Carrasco; Guiomar E Peña-Martí
Journal:  Cochrane Database Syst Rev       Date:  2011-03-16

4.  Increased Von Willebrand factor, decreased ADAMTS13 and thrombocytopenia in melioidosis.

Authors:  Emma Birnie; Gavin C K W Koh; Ester C Löwenberg; Joost C M Meijers; Rapeephan R Maude; Nicholas P J Day; Sharon J Peacock; Tom van der Poll; W Joost Wiersinga
Journal:  PLoS Negl Trop Dis       Date:  2017-03-15

5.  Evaluation of Antithrombotic Activities of Solanum xanthocarpum and Tinospora cordifolia.

Authors:  Onila Lugun; Sobharani Bhoi; Priyanka Kujur; D Vinay Kumar; William R Surin
Journal:  Pharmacognosy Res       Date:  2018 Jan-Mar

6.  Cerebrovascular Disease in Patients with COVID-19: A Review of the Literature and Case Series.

Authors:  Sujan T Reddy; Tanu Garg; Chintan Shah; Fábio A Nascimento; Rajeel Imran; Peter Kan; Ritvij Bowry; Nicole Gonzales; Andrew Barreto; Abhay Kumar; John Volpi; Vivek Misra; David Chiu; Rajan Gadhia; Sean I Savitz
Journal:  Case Rep Neurol       Date:  2020-06-11

7.  Novel biomarkers for early prediction of sepsis-induced disseminated intravascular coagulation in a mouse cecal ligation and puncture model.

Authors:  Jingchun Song; Dunzhong Hu; Chao He; Tao Wang; Xuefeng Liu; Linhao Ma; Zhaofen Lin; Zili Chen
Journal:  J Inflamm (Lond)       Date:  2013-03-05       Impact factor: 4.981

8.  Predictors for Early Identification of Hepatitis C Virus Infection.

Authors:  Mei-Hua Tsai; Kuei-Hsiang Lin; Kuan-Tsou Lin; Chi-Ming Hung; Hung-Shiang Cheng; Yu-Chang Tyan; Hui-Wen Huang; Bintou Sanno-Duanda; Ming-Hui Yang; Shyng-Shiou Yuan; Pei-Yu Chu
Journal:  Biomed Res Int       Date:  2015-08-27       Impact factor: 3.411

Review 9.  Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies.

Authors:  Alessandro Allegra; Vanessa Innao; Andrea Gaetano Allegra; Caterina Musolino
Journal:  Ann Hematol       Date:  2020-07-15       Impact factor: 3.673

10.  Phospholipase D1 regulation of TNF-alpha protects against responses to LPS.

Authors:  Marc-Andre Urbahn; Sonja Charlotte Kaup; Friedrich Reusswig; Irena Krüger; Martina Spelleken; Kerstin Jurk; Meike Klier; Philipp A Lang; Margitta Elvers
Journal:  Sci Rep       Date:  2018-07-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.